AI-generated treatment recommendations for precision oncology

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses local AI models to analyze comprehensive molecular tumor profiles and generate potential treatment options. The AI-generated options are then compared to actual personalized therapy recommendations to see if they are non-inferior. Eligible participants are adults with advanced solid tumors, good performance status (ECOG 0-1), and a planned comprehensive molecular analysis. The study is led by Charité – Universitätsmedizin Berlin with no listed collaborators and takes place at Charité in Berlin.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* advanced solid tumor
* \>=18years
* ECOG 0-1
* comprehensive molecular tumor analysis planned

Exclusion Criteria:

* lack of capacity to consent
* hematological neoplasm

Where it's running

• Charité - Universitätsmedizin Berlin
  Berlin, Germany Recruiting

Study contacts

• Study coordinator: Damian T Rieke, MD
• Email: cccc@charite.de
• Phone: +4930450 564 222

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How to talk about vaccines: does different communication help people decide to get vaccinated?

  This online randomized trial tests whether specific communication formats can improve knowledge and willingness to get vaccinated for TBE (Germany) or yellow fever (Colombia).

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT07921121

• DHEA add-on to standard antidepressants for treatment-resistant depression

  This trial tests whether adding 100 mg/day of DHEA to patients’ current antidepressant treatment helps people with treatment-resistant depression feel better.

  Recruiting at 9 sites Phase 3 Charite University, Berlin, Germany · Berlin, State of Berlin and 8 other locations · NCT07843927

• Context-adapted quality indicators for early sepsis care in Sub-Saharan Africa

  A group of sepsis experts in Sub-Saharan Africa will participate in a series of online surveys and feedback meetings to agree on practical quality indicators for early sepsis care.

  Recruiting Charite University, Berlin, Germany · Kumasi · NCT07711535

• TNPO2-related disorders registry

  This international registry tests how TNPO2 gene variants relate to neurodevelopmental issues by collecting medical, genetic, and developmental data from people with pathogenic TNPO2 variants.

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT07699510

• International TRPM3 Disorder Registry

  This registry tests how TRPM3-associated disorders progress by collecting and comparing patient data over time to learn about treatments and quality of life.

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT07690111

• High-fiber diet with short-term fasting during melanoma immunotherapy

  This study tests whether a high-fiber diet, with or without short-term fasting, can help people with melanoma better tolerate and respond to immune checkpoint inhibitors.

  Recruiting Charite University, Berlin, Germany · Berlin, State of Berlin · NCT07680452

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.